cdmo.directory
← Compare landing

Boston Institute of Biotechnology, LLC vs Sophia CDMO

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBoston Institute of Biotechnology, LLCSophia CDMO
SummaryFull-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L.European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lyophilization (Freeze Drying)
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Peptide
  • Microbiome Therapeutic
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • Max bioreactor: Mega / blockbuster (>10,000 L)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Single-Use / Disposable
  • Stainless Steel
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • Max bioreactor: Large commercial (≤10,000 L)
  • Expression: Microbial
  • Stainless Steel
Locations
  • Southborough, Southborough, Massachusetts, United States
  • Zhangjiang (P01), Shanghai, Shanghai, China
  • Lingang (IP02), Shanghai, Shanghai, China
  • Lingang (IP03), Shanghai, Shanghai, China
  • Headquarters, Southborough, Massachusetts, United States
  • Headquarters, Pamplona, Navarre, Spain
  • Headquarters, Basel, Basel-Stadt, Switzerland
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Boston Institute of Biotechnology, LLC alternatives · Sophia CDMO alternatives

Markdown mirror: /compare/bostonbib/sophiacdmo.md